Gil, Jeovanis

Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies

Pomeshchik, Y., Klementieva, O., Gil, J., Martinsson, I., Hansen, M. G., de Vries, T., Sancho-Balsells, A., Russ, K., Savchenko, E., Collin, A., et al. (2020) · Stem Cell Reports

Alzheimer's disease research and treatmentsPluripotent Stem Cells Research

Cited by 95

Clinical protein science in translational medicine targeting malignant melanoma

Gil, J., Betancourt, L. H., Pla, I., Sanchez, A., Appelqvist, R., Miliotis, T., Kuras, M., Oskolas, H., Kim, Y., Horvath, Z., et al. (2019) · Cell Biology and Toxicology

Melanoma and MAPK PathwaysAdvanced Proteomics Techniques and Applications

Cited by 45

Proteomic workflows for high-quality quantitative proteome and post-translational modification analysis of clinically relevant samples from formalin-fixed paraffin-embedded archives

Kuras, M., Woldmar, N., Kim, Y., Hefner, M., Malm, J., Moldvay, J., Döme, B., Fillinger, J., Pizzatti, L., Gil, J., et al. (2021) · Journal of Proteome Research

Advanced Proteomics Techniques and ApplicationsAdvanced Biosensing Techniques and Applications

Cited by 36

The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes

Betancourt, L. H., Szasz, A. M., Kuras, M., Rodriguez Murillo, J., Sugihara, Y., Pla, I., Horvath, Z., Pawłowski, K., Rezeli, M., Miharada, K., et al. (2019) · Cancers

Melanoma and MAPK PathwaysCutaneous Melanoma Detection and Management

Cited by 24

Deep proteomic analysis on biobanked paraffine-archived melanoma with prognostic/predictive biomarker read-out

Szadai, L., Velasquez, E., Szeitz, B., Almeida, N. P. D., Domont, G., Betancourt, L. H., Gil, J., Marko-Varga, M., Oskolas, H., Jánosi, Á. J., et al. (2021) · Cancers

Advanced Proteomics Techniques and ApplicationsCutaneous Melanoma Detection and Management

Cited by 18

Mitochondrial and immune response dysregulation in melanoma recurrence

Szadai, L., Guedes, J. D. S., Woldmar, N., de Almeida, N. P., Jánosi, Á. J., Rajeh, A., Kovács, F., Kriston, A., Migh, E., Wan, G., et al. (2023) · Clinical and Translational Medicine

Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management

Cited by 18

A perspective on integrating digital pathology, proteomics, clinical data and AI analytics in cancer research

Guedes, J., Woldmar, N., Szasz, A. M., Wieslander, E., Pawłowski, K., Horvatovich, P., Malm, J., Szadai, L., Németh, I. B., Marko-Varga, G., et al. (2025) · Journal of Proteomics

AI in cancer detectionRadiomics and Machine Learning in Medical Imaging

Cited by 16

A biobanking turning-point in the use of formalin-fixed, paraffin tumor blocks to unveil kinase signaling in melanoma

Velasquez, E., Szadai, L., Zhou, Q., Kim, Y., Pla, I., Sanchez, A., Appelqvist, R., Oskolas, H., Marko‐Varga, M., Lee, B., et al. (2021) · Clinical and Translational Medicine

Advanced Proteomics Techniques and ApplicationsMelanoma and MAPK Pathways

Cited by 13